Literature DB >> 21056367

[Symptomatic approach to chronic pudendal pain].

J-J Labat1, D Delavierre, L Sibert, J Rigaud.   

Abstract

INTRODUCTION: Pudendal neuralgia is a recently identified and now clearly recognized clinical entity. This chronic disabling pain is due to a pelviperineal tunnel syndrome.
MATERIAL AND METHODS: Review of the literature based on a Medline search of articles devoted to this subject.
RESULTS: The diagnosis is purely clinical, based on simple consensual criteria (Nantes Criteria): pain situated in the anatomical territory of the pudendal nerve, worse on sitting, not usually waking the patient at night, not accompanied by any objective perineal sensory loss with a positive anaesthetic block of the pudendal nerve at the ischial spine.
CONCLUSION: The diagnosis of pudendal neuralgia is straightforward when the patient's symptoms remain confined to these diagnostic criteria, which are all essential for the diagnosis. However, the patient often presents associated urinary, anorectal, sexual, neuromuscular and hypersensitization signs, which can complicate the diagnostic approach and therapeutic management.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056367     DOI: 10.1016/j.purol.2010.08.055

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  3 in total

1.  [Not Available].

Authors:  Imad Ziouziou; Hassan Bennani; Mohamed Zizi; Tarik Karmouni; Khalid El Khader; Abdellatif Koutani; Ahmed Iben Attya Andaloussi
Journal:  Can Urol Assoc J       Date:  2013-07       Impact factor: 1.862

2.  [Pudendal neuralgia: Report on three cases].

Authors:  Imad Ziouziou; Yassine Rhannam; Souhail Yacoubi; Tariq Karmouni; Khalid El Khader; Abdellatif Koutani; Ahmed Iben Attya Andaloussi; Anass Nouri; Philippe Barre; Mohamed Nouri
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

Review 3.  Pelvic floor therapies in chronic pelvic pain syndrome.

Authors:  Ragi Doggweiler; Adam F Stewart
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.